Ian Sacks - Feb 1, 2023 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role
Director
Signature
/s/ Delano W. Ladd, Attorney-in-Fact
Stock symbol
HQY
Transactions as of
Feb 1, 2023
Transactions value $
$0
Form type
4
Date filed
2/3/2023, 10:49 AM
Previous filing
Oct 21, 2022
Next filing
Dec 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Award $0 +1.06K +0.98% $0.00 110K Feb 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HQY Stock Option (right to buy) 15K Feb 1, 2023 Common Stock 15K $21.27 Direct F2
holding HQY Stock Option (right to buy) 15K Feb 1, 2023 Common Stock 15K $14.00 Direct F2
holding HQY Stock Option (right to buy) 15K Feb 1, 2023 Common Stock 15K $25.39 Direct F2
holding HQY Stock Option (right to buy) 8.02K Feb 1, 2023 Common Stock 8.02K $66.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 265 shares on February 1, 2023. The remaining restricted stock units vest as to 265 shares on each of May 1, August 1, and November 1, of 2023. Vested shares will be delivered to the reporting person upon vesting.
F2 The option is immediately exercisable.

Remarks:

The Power of Attorney given by Mr. Sacks was previously filed with the U.S. Securities and Exchange Commission on February 3, 2017 as an exhibit to a statement on Form 4 filed by Mr. Sacks with respect to HealthEquity, Inc. and is hereby incorporated by reference.